Edwards Lifesciences Corp · Healthcare · Medical Equipment
As of 2026-06-26, Edwards Lifesciences Corp (EW) has a 3-month relative strength percentile of 58 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.8%, relative volume 2.85×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
58 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
EW is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 7.7% / 10.5%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
EW is held by 4 ETFs as of Mar 2026. Top owner: IVW at 0.07% weight, $45M notional. Top 3 carry $109M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IVWiShares S&P 500 Growth ETF | 0.07% | $45M |
| IVEiShares S&P 500 Value ETF | 0.09% | $43M |
| IUSViShares Core S&P U.S. Value ETF | 0.09% | $21M |
| IUSGiShares Core S&P U.S. Growth ETF | 0.07% | $18M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EW Jan avg: -0.25% median: 0.33% win: 50% σ: 3.72% n: 4 2022-04-12 → 2026-05-29 | EW Feb avg: 4.54% median: 5.58% win: 75% σ: 4.02% n: 4 2022-04-12 → 2026-05-29 | EW Mar avg: 2.31% median: 2.02% win: 75% σ: 8.19% n: 4 2022-04-12 → 2026-05-29 | EW Apr avg: -1.91% median: 4.15% win: 60% σ: 9.42% n: 5 2022-04-12 → 2026-05-29 | EW May avg: 0.17% median: 2.62% win: 60% σ: 4.25% n: 5 2022-04-12 → 2026-05-29 | EW Jun avg: 3.14% median: 3.15% win: 50% σ: 7.67% n: 4 2022-04-12 → 2026-05-29 (current) | EW Jul avg: -9.40% median: -5.79% win: 50% σ: 16.91% n: 4 2022-04-12 → 2026-05-29 | EW Aug avg: -0.92% median: -2.13% win: 50% σ: 9.62% n: 4 2022-04-12 → 2026-05-29 | EW Sep avg: -6.94% median: -6.98% win: 0% σ: 2.31% n: 4 2022-04-12 → 2026-05-29 | EW Oct avg: -3.20% median: -3.24% win: 50% σ: 8.45% n: 4 2022-04-12 → 2026-05-29 | EW Nov avg: 6.13% median: 6.37% win: 100% σ: 0.69% n: 4 2022-04-12 → 2026-05-29 | EW Dec avg: 2.83% median: 1.06% win: 50% σ: 7.20% n: 4 2022-04-12 → 2026-05-29 |